metoclopramide has been researched along with Apoplexy in 4 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Excerpt | Relevance | Reference |
---|---|---|
"This study suggests that metoclopramide may reduce the rate of pneumonia and may improve other clinical outcomes in patients with subacute stroke fed via nasogastric tube." | 9.20 | Safety and effect of metoclopramide to prevent pneumonia in patients with stroke fed via nasogastric tubes trial. ( Karunatilake, D; Lally, F; Roffe, C; Sim, J; Warusevitane, A, 2015) |
"Etiology identification of the stroke included cardiogenic pathology and coagulopathy, but acitretin treatment was considered the likeliest explanation." | 7.71 | Acitretin-associated thrombotic stroke. ( Davani, S; Kantelip, JP; Muret, P; Royer, B; Ziegler, F, 2002) |
"This study suggests that metoclopramide may reduce the rate of pneumonia and may improve other clinical outcomes in patients with subacute stroke fed via nasogastric tube." | 5.20 | Safety and effect of metoclopramide to prevent pneumonia in patients with stroke fed via nasogastric tubes trial. ( Karunatilake, D; Lally, F; Roffe, C; Sim, J; Warusevitane, A, 2015) |
"Etiology identification of the stroke included cardiogenic pathology and coagulopathy, but acitretin treatment was considered the likeliest explanation." | 3.71 | Acitretin-associated thrombotic stroke. ( Davani, S; Kantelip, JP; Muret, P; Royer, B; Ziegler, F, 2002) |
"Treatments provided to improve dysphagia are aimed at accelerating recovery of swallowing function and reducing these risks." | 2.58 | Swallowing therapy for dysphagia in acute and subacute stroke. ( Bath, PM; Everton, LF; Lee, HS, 2018) |
" Clinicians should attempt to treat patients with the lowest effective dosage of medication for the briefest therapeutic period to minimize the risks of adverse reactions." | 1.31 | Metoclopramide-induced supersensitivity psychosis. ( Lu, ML; Pan, JJ; Shen, WW; Su, KP; Teng, HW, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bath, PM | 1 |
Lee, HS | 1 |
Everton, LF | 1 |
Warusevitane, A | 1 |
Karunatilake, D | 1 |
Sim, J | 1 |
Lally, F | 1 |
Roffe, C | 1 |
Lu, ML | 1 |
Pan, JJ | 1 |
Teng, HW | 1 |
Su, KP | 1 |
Shen, WW | 1 |
Royer, B | 1 |
Ziegler, F | 1 |
Muret, P | 1 |
Davani, S | 1 |
Kantelip, JP | 1 |
1 review available for metoclopramide and Apoplexy
Article | Year |
---|---|
Swallowing therapy for dysphagia in acute and subacute stroke.
Topics: Acupuncture Therapy; Acute Disease; Deglutition; Deglutition Disorders; Electric Stimulation Therapy | 2018 |
1 trial available for metoclopramide and Apoplexy
Article | Year |
---|---|
Safety and effect of metoclopramide to prevent pneumonia in patients with stroke fed via nasogastric tubes trial.
Topics: Aged; Aged, 80 and over; Diarrhea; Dopamine D2 Receptor Antagonists; Double-Blind Method; Female; Fo | 2015 |
2 other studies available for metoclopramide and Apoplexy
Article | Year |
---|---|
Metoclopramide-induced supersensitivity psychosis.
Topics: Aged; Antiemetics; Antipsychotic Agents; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Hallucina | 2002 |
Acitretin-associated thrombotic stroke.
Topics: Acitretin; Analgesics; Anticoagulants; Antiemetics; Dextropropoxyphene; Domperidone; Female; Headach | 2002 |